Clinical Trial Update: Alendronate for Prevention of AntiRetroviral Therapy-associated Bone Loss [Phase 4]

View source ↗

Summary

Phase 4 trial update on alendronate for prevention of bone loss associated with antiretroviral therapy has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Demineralization

Drugs mentioned

• alendronate (alendronate)

Snippet

Sponsor: University College Dublin | Conditions: Bone Demineralization | Phase 4 | Status: TERMINATED